ProShares UltraShort Nasdaq Biotech (BIS)

Add to Watchlists
Create an Alert
30.50 +0.65  +2.18% NASDAQ Apr 24, 8:00PM BATS Real time Currency in USD
View Full Chart
BIS Price Chart

BIS Description

ProShares UltraShort Nasdaq Biotech is a long-short equity fund managed by ProShares that tracks the NASDAQ Biotechnology TR USD index and has 101.73M USD assets under management. The fund has a net expense ratio of 0.95% and is traded on the NASDAQ.

BIS Key Info

Expense Ratio (1-9-15) 0.95%
Assets Under Management (4-24-15) 101.73M
30-Day Average Volume (4-24-15) 540643.4
Net Asset Value (4-24-15) 30.50
Discount or Premium to NAV (4-24-15) 0.00%
Turnover Ratio --

BIS Asset Allocation

Type % Net % Long % Short
Cash 299.6% 299.6% 0.00%
Stock -199.5% 0.23% 199.7%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other -0.13% 0.00% 0.13%
As of Dec. 31, 2014

BIS Region Exposure

Americas --
North America --
Latin America --
Greater Europe --
United Kingdom --
Europe Developed --
Europe Emerging --
Africa/Middle East --
Greater Asia --
Japan --
Australasia --
Asia Developed --
Asia Emerging --
Market Classification
% Developed Markets --
% Emerging Markets --
Date Unavailable
Region breakdown data is calculated by using the long position holdings of the portfolio.

BIS Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.00%
Healthcare 0.00%
Industrials 0.00%
Real Estate 0.00%
Technology 0.00%
Utilities 0.00%
As of Dec. 31, 2014

BIS Stock Market Capitalization

Giant --
Large --
Medium --
Small --
Micro --
As of Dec. 31, 2014
View More Holdings Info

BIS Top 10 Holdings

Name % Weight Price Chg %
Nasdaq Biotechnology Index Swap Bank Of America, Na 101.6% -- --
Nasdaq Biotechnology Index Swap Societe Generale 44.54% -- --
Nasdaq Biotechnology Index Swap Ubs Ag 38.01% -- --
Nasdaq Biotechnology Index Swap Deutsche Bank Ag 11.46% -- --
Nasdaq Biotechnology Index Swap Credit Suisse International 3.82% -- --
Nasdaq Biotechnology Index Swap Morgan Stanley & Co. International Plc 0.23% -- --
Nasdaq Biotechnology Index Swap Morgan Stanley & Co. International Plc - Ca 0.23% -- --
Ishares Biotech (Ibb) Swap Morgan Stanley & Co. International Plc 0.10% -- --
Nasdaq Biotechnology Index Swap Citibank, N.A. 0.06% -- --
Ishares Biotech (Ibb) Swap Bank Of America, Na 0.03% -- --
As of Dec. 31, 2014
Get Quote for
Advertisement

BIS Basic Info

Style
Broad Asset Class Alternative
Broad Category Alternative
Prospectus Objective Specialty - Health
Fund Owner Firm Name ProShares
Benchmark Index
NASDAQ Biotechnology TR USD -200.0%
Key Dates
Inception Date 4/6/2010
Last Annual Report Date 5/31/2014
Last Prospectus Date 1/9/2015
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund Yes
Leveraged Fund Yes
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund Yes
Has Dividend Investment Plan No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available RRSP No

BIS Manager Info

Name Tenure
Charles Lowery 1.50 yrs
Michael Neches 1.50 yrs

BIS Risk Info

Beta -1.629
30 Day Average Volatility 45.58%

BIS Fundamentals

Dividend Yield TTM (4-24-15) 0.00%
Weighted Average PE Ratio --
Weighted Average Price to Sales Ratio --
Weighted Average Price to Book Ratio --
Weighted Median ROE --
Weighted Median ROA --
Forecasted Dividend Yield --
Forecasted PE Ratio --
Forecasted Price to Sales Ratio --
Forecasted Price to Book Ratio --
Number of Holdings 19
As of Dec. 31, 2014

BIS Growth Estimates

Forecasted 5 Yr Earnings Growth --
Forecasted Book Value Growth --
Forecasted Cash Flow Growth --
Forecasted Earnings Growth --
Forecasted Revenue Growth --
As of Dec. 31, 2014

BIS Performance

  Returns Total Returns
1M -5.84% -5.84%
3M -24.17% -24.17%
6M -42.45% -42.45%
1Y -66.65% -66.65%
3Y -93.42% -93.42%
5Y -97.52% -97.52%
As of April 24, 2015

BIS Flows

1M 38.45M
3M 68.68M
6M 63.29M
YTD 68.68M
1Y 120.35M
3Y 163.59M
5Y 165.03M
As of March 31, 2015
Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.